Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$118.33

3.02 (2.62%)

07:21
02/27/18
02/27
07:21
02/27/18
07:21

GW Pharmaceuticals receives orphan drug designation for cannabidiol treatment

GW Pharmaceuticals announced that the European Medicines Agency has granted orphan drug designation for cannabidiol for the treatment of tuberous sclerosis. GW is currently recruiting a Phase 3 clinical trial of Epidiolex as an adjunctive therapy for the treatment of seizures associated with TS, with data expected in the second half of 2018. Subject to positive results, GW expects to submit regulatory applications in 2019 for Epidiolex in TS in both the U.S. and Europe. TS is multisystem, genetic disease that causes benign tumors to grow in the brain and on other vital organs. TS can be life threatening in patients with severe symptoms, including drug resistant seizures and kidney failure. Up to 80 to 90% of individuals with TS will develop epilepsy during their lifetime, with onset typically in childhood. The seizures are often severe, and up to two-thirds of TS patients do not respond adequately to available medical therapies. There are significant co-morbidities associated with TS including cognitive impairment, autism spectrum disorders, developmental delay with severe learning disability and neurobehavioral disorders in individuals with TS. The EMA orphan designation is a status assigned to a medicine intended for use against a rare condition and allows a pharmaceutical company to benefit from incentives offered by the EU to develop a medicine for the treatment, prevention or diagnosis of a disease that is life-threatening or a chronically debilitating rare disease. These incentives can include reduced fees and protection from competition once the medicine is placed on the market. GW has already received orphan drug designation from the FDA for CBD in the treatment of TS.

  • 27

    Jun

GWPH GW Pharmaceuticals
$118.33

3.02 (2.62%)

12/29/17
LEER
12/29/17
NO CHANGE
LEER
Outperform
GW filing acceptance, FDA panel in line with expectations, says Leerink
Leerink analyst Paul Matteis said the FDA accepting the Epidiolex new drug application and granting of priority review were in line with expectations given the three positive late-stage studies and the unmet need for the two rare orphan epilepsies. The analyst thinks an Advisory Committee was likely given that Epidiolex is a plant-derived cannabinoid drug seeking a primarily pediatric indication. Matteis yesterday reiterated an Overweight rating on shares of GW Pharmaceuticals.
01/23/18
LEER
01/23/18
NO CHANGE
Target $153
LEER
Outperform
Leerink cautiously optimistic ahead of GW Pharmaceuticals CBDV Phase 2 data
Leerink analyst Paul Matteis reiterates an Outperform rating on GW Pharmaceuticals, while lowering his price target on the shares to $153 from $154, ahead of CBDV Phase II data in partial-onset seizures in Q1. While he acknowledges that is difficult to garner conviction in the Phase 2, his analysis of pre-clinical results - compared side-by-side to cannabidiol - instills him with "cautious optimism" on the program, while he believes that the little credit priced into the stock for CBDV sets up an upside skewed risk/reward on the upcoming data readout this quarter.
02/06/18
CANT
02/06/18
NO CHANGE
Target $192
CANT
Overweight
GW Pharmaceuticals price target lowered to $192 from $208 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros lowered his price target for GW Pharmaceuticals to $192 following the company's Q1 financial results and recent equity raise. The analyst, however, believes the shares remain "significantly undervalued," based on his assessment of Epidiolex's opportunity in treating orphan pediatric epileptic conditions. He reiterates an Overweight rating on GW.
02/22/18
CANT
02/22/18
NO CHANGE
Target $192
CANT
Overweight
GW Pharmaceuticals shares could recover quickly, says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros believes GW Pharmaceuticals shares could recover quickly from the selloff on the negative results with GWP42006 in adult patients with focal seizures. The analyst highlights the announcement of an advisory committee hearing for Epidiolex on April 18. The "clear near-term focus" is the successful commercialization of Epidiolex for pediatric pharmacoresistant seizures upon potential approval in the second half of 2018, Piros tells investors in a research note. He keeps an Overweight rating on GW shares with a $192 price target.

TODAY'S FREE FLY STORIES

EFA

iShares MSCI EAFE Index Fund

$66.50

0.01 (0.02%)

06:54
08/15/18
08/15
06:54
08/15/18
06:54
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEFT

Euronet

$94.54

0.66 (0.70%)

06:54
08/15/18
08/15
06:54
08/15/18
06:54
Conference/Events
Euronet management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 16

    Aug

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

JNK

SPDR Barclays High Yield Bond

$35.86

0.065 (0.18%)

06:53
08/15/18
08/15
06:53
08/15/18
06:53
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$22.78

0.025 (0.11%)

06:53
08/15/18
08/15
06:53
08/15/18
06:53
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIOD

Diodes

$37.81

0.07 (0.19%)

06:52
08/15/18
08/15
06:52
08/15/18
06:52
Conference/Events
Diodes management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.97

0.16 (0.19%)

06:52
08/15/18
08/15
06:52
08/15/18
06:52
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.50

0.155 (0.13%)

06:52
08/15/18
08/15
06:52
08/15/18
06:52
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$120.14

-0.32 (-0.27%)

06:51
08/15/18
08/15
06:51
08/15/18
06:51
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$14.17

0.075 (0.53%)

06:50
08/15/18
08/15
06:50
08/15/18
06:50
Technical Analysis
iShares Silver Trust: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$52.59

0.48 (0.92%)

06:50
08/15/18
08/15
06:50
08/15/18
06:50
Conference/Events
Cornerstone OnDemand management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

USLV

VelocityShares 3x Long Silver ETN

$7.31

0.12 (1.67%)

06:49
08/15/18
08/15
06:49
08/15/18
06:49
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

06:49
08/15/18
08/15
06:49
08/15/18
06:49
Conference/Events
Cabot Microelectronics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

IYR

DJ US Real Estate Index Fund

$81.16

0.44 (0.55%)

06:48
08/15/18
08/15
06:48
08/15/18
06:48
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLDR

Builders FirstSource

$16.86

0.85 (5.31%)

06:48
08/15/18
08/15
06:48
08/15/18
06:48
Conference/Events
Builders FirstSource management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 10

    Sep

  • 11

    Sep

  • 06

    Nov

BMS

Bemis

$49.51

0.12 (0.24%)

, BERY

Berry Global

$45.77

-0.07 (-0.15%)

06:48
08/15/18
08/15
06:48
08/15/18
06:48
Upgrade
Bemis, Berry Global, Graphic Packaging rating change  »

Bemis upgraded to Sector…

BMS

Bemis

$49.51

0.12 (0.24%)

BERY

Berry Global

$45.77

-0.07 (-0.15%)

GPK

Graphic Packaging

$14.30

0.19 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IBB

iShares Nasdaq Biotechnology Index

$117.24

0.7 (0.60%)

06:48
08/15/18
08/15
06:48
08/15/18
06:48
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$118.97

0.8 (0.68%)

06:47
08/15/18
08/15
06:47
08/15/18
06:47
Periodicals
UPS reaches labor deal with aircraft mechanics, WSJ reports »

UPS has tentatively…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$25.69

-0.41 (-1.57%)

06:47
08/15/18
08/15
06:47
08/15/18
06:47
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$24.20

0.07 (0.29%)

06:46
08/15/18
08/15
06:46
08/15/18
06:46
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$29.59

(0.00%)

06:46
08/15/18
08/15
06:46
08/15/18
06:46
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$87.94

1.12 (1.29%)

06:46
08/15/18
08/15
06:46
08/15/18
06:46
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$42.76

0.265 (0.62%)

06:45
08/15/18
08/15
06:45
08/15/18
06:45
Technical Analysis
MSCI Emerging Markets Index: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
08/15/18
08/15
06:45
08/15/18
06:45
General news
Breaking General news story  »

Week of 8/10 MBA Mortgage…

EWW

iShares MSCI Mexico

$50.67

1.11 (2.24%)

06:44
08/15/18
08/15
06:44
08/15/18
06:44
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$25.60

0.095 (0.37%)

06:43
08/15/18
08/15
06:43
08/15/18
06:43
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.